ArticleInternational journal of nanomedicine2019

Development of anti-HER2-targeted doxorubicin-core-shell chitosan nanoparticles for the treatment of human breast cancer.

Parichart Naruphontjirakul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.